1524-9557
Published by: Wolters Kluwer Health, Inc.
https://journals.lww.com/immunotherapy-journal/pages/default.aspx
| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Immunology | 175 | 25 | 20 | 9 |
| Medicine | 1799 | 69 | 57 | 14 |
The journal covers a variety of subjects, including Immunology, Immunotherapy, Cancer research, Internal medicine and Antigen. The study on Immunology presented in the journal intersects with subjects under the field of Cytotoxic T cell. Topics in Cytotoxic T cell were tackled in line with various other fields like T lymphocyte and Cell biology.
The Immunotherapy research presented in the journal explores the relationship between Melanoma and the closely related topic of Pathology. The research on Cancer research tackled can also make contributions to studies in the areas of Cell culture, Interleukin 12, Lymphokine-activated killer cell and In vivo. The study of Internal medicine encompasses disciplines such as Gastroenterology, as well as fields such as Toxicity, all of which overlap with one another.
In it, Molecular biology, Antibody and Virology are investigated in conjunction with one another to address concerns in Antigen research. Many of the studies tackled connect Immune system with a similar field of study like Vaccination. Discussions in Journal of Immunotherapy are anchored in the subject of Cytokine and the similar topic of Tumor necrosis factor alpha.
The journal publications cover a variety of subjects, including Immunology, Immunotherapy, Antigen, Immune system and Cytotoxic T cell. The journal articles focus on Immunology but the discussions also offer insight into other areas such as Cancer research and Melanoma. The most cited papers facilitate discussions on Immunotherapy that incorporate concepts from other fields like Adoptive cell transfer, T lymphocyte and Cytokine.
Journal of Immunotherapy tackles a plethora of topics, such as Internal medicine, Oncology, Immunotherapy, Adverse effect and Cancer. The presented research on Internal medicine deals specifically with Melanoma but it also addresses topics in Uveitis. Clinical trial, Chemotherapy, Retrospective cohort study, Lymph node and Cohort are some topics wherein Oncology research discussed in Journal of Immunotherapy have an impact.
Journal of Immunotherapy aims to reinforce research in the subjects of Immune system and Immunology by tackling studies in Immunotherapy. Immunology research presented in Journal of Immunotherapy encompasses a variety of subjects, including Transplantation and Pneumonia. The journal explores issues in Cancer which can be linked to other research areas like Logistic regression and Ejection fraction.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Journal of Immunotherapy (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Journal of Immunotherapy (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 16.67% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 16.00% were posted by at least one author from the top 10 institutions publishing in the journal. Another 4.00% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 20.00% of all publications and 60.00% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
Fausto Petrelli;Giulia Grizzi;Michele Ghidini;Antonio Ghidini
(2020)Miriam Möller;Steffi Turzer;Wolfgang Schütte;Barbara Seliger
(2020)John E Mullinax;MacLean Hall;Matthew Beatty;Amy M Weber
(2021)Giulio Metro;Giuseppe Luigi Banna;Diego Signorelli;Alessio Gili
(2020)Michiel C T van Zeijl;John B A G Haanen;Michel W J M Wouters;Liesbeth C de Wreede
(2020)Biman C Paria;Noam Levin;Frank J Lowery;Anna Pasetto
(2021)For those interested in healthcare careers related to Medicine in the USA, exploring nursing pathways can provide flexible and accelerated options. Understanding how many years does it take to be a nurse practitioner is essential for planning your education and entry into advanced clinical roles.
Many students benefit from accelerated BSN programs, which allow registered nurses to quickly earn a Bachelor of Science in Nursing, significantly shortening the path to advanced practice roles. For RNs aiming to become nurse practitioners, RN to NP programs offer targeted curricula to bridge the gap efficiently.
Those without a nursing background can consider online direct entry MSN programs, designed for non-nurses to enter the field through an accelerated master's degree. These programs provide a streamlined route into nursing and subsequent advanced practice, complementing medical knowledge gained through traditional medical degrees.
By exploring these online degrees and career pathways, prospective students can tailor their educational journey to meet both time constraints and professional goals in the rapidly evolving healthcare sector.
